Similar articles

• Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.

  Maruyama K, Shirato S. Maruyama K, et al. J Glaucoma. 2006 Aug;15(4):341-5. doi: 10.1097/01.ijg.0000212240.11219.49. J Glaucoma. 2006. PMID: 16865013 Clinical Trial.
• [Neuroprotection in glaucoma].

  Kuprjanowicz L, Karczewicz D. Kuprjanowicz L, et al. Ann Acad Med Stetin. 2007;53 Suppl 1:22-9. Ann Acad Med Stetin. 2007. PMID: 19425476 Review. Polish.
• [New drugs in glaucoma therapy].

  Gramer E. Gramer E. Klin Monbl Augenheilkd. 1998 Jul;213(1):aA10-2. Klin Monbl Augenheilkd. 1998. PMID: 9743931 German. No abstract available.
• Latanoprost therapy in patients with glaucoma and ocular hypertension inadequately controlled with carteolol.

  Yasar T, Ozdemir M, Andi I, Ozdemir G, Simsek S. Yasar T, et al. Jpn J Ophthalmol. 2004 Mar-Apr;48(2):172-3. doi: 10.1007/s10384-003-0032-0. Jpn J Ophthalmol. 2004. PMID: 15060799 No abstract available.
• [The role of Cosopt in glaucoma treatment].

  Călugăru D, Călugăru M. Călugăru D, et al. Oftalmologia. 2008;52(4):15-25. Oftalmologia. 2008. PMID: 19354158 Review. Romanian.